Project Grant HT94252311079
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Awardee
Mayo Clinic (Y2K4F9RPRRG7)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $322,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic in Rochester, Minnesota. The grant, with a performance period from April 1, 2024 to March 31, 2026, supports research on "MYELOPEROXIDASE PROMOTES PERSISTENT FIBROSIS." As a renowned non-profit academic medical center, Mayo Clinic will leverage its expertise in clinical care, biomedical research, and medical...
This Project Grant award of $1,187,150.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Cleveland VA Medical Research & Education Foundation. The research aims to develop and evaluate non-endoscopic screening methods for detecting Barrett's esophagus and esophageal cancer in at-risk veterans without a history of chronic gastroesophageal reflux. The award has a performance period from September 1, 2024 to...
The Defense Health Agency awarded Mayo Clinic Jacksonville $3,232,027 under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2023 through September 14, 2027. Through this award, Mayo Clinic will integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for service members...
Mayo Clinic will receive $795,000 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct the project "PHARMACODYNAMIC BIOMARKER-GUIDED METABOLIC COLLAPSE OF IDH-MUTANT GLIOMA" from September 2021 through September 2024. This Project Grant aims to develop medical solutions for the battlefield by investigating pharmacodynamic biomarkers to guide targeted metabolic therapies for the treatment of isocitrate...
Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
The U.S. Defense Health Agency awarded a $1,038,499.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the American Society for Clinical Pathology (ASCP), a non-profit organization. The grant, entitled "Enhancing Precision Oncology for Underserved Breast Cancer Patients through Deep Learning-Aided Histopathology Analysis", will fund research to develop advanced deep learning algorithms for improving breast cancer diagnostics and treatment,...
The Defense Health Agency awarded a $1,162,900 Project Grant to the Mayo Clinic in Rochester, MN under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 15, 2025, is for the project "LAUNCHING THE ERA OF MELANOMA SURVIVORSHIP: DEFINING TREATMENT TARGETS IN QUALITY OF LIFE AND MENTAL HEALTH" and runs through July 14, 2028. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans,...
The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
This federal Project Grant award of $1,782,155.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Mayo Clinic to identify novel drug targets for lethal prostate cancer using liquid biopsy techniques. The award period runs from April 1, 2025 to March 31, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations...